---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-001111"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T06:49:58.514452+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma enters $60M ATM equity offering with A.G.P./Alliance Global Partners

## Summary
- On Oct 27, 2023, IGC Pharma entered an ATM sales agreement with A.G.P./Alliance Global Partners to sell up to $60M of common stock.
- A.G.P. will receive a 3% commission on gross proceeds; the company reimburses up to $40K legal fees and $10K annual maintenance.
- The prior ATM agreement with The Benchmark Company (Jan 2021) was terminated.
- Board initially reserved shares based on Oct 25 closing price of $0.29 per share.
- Agreement terminates upon sale of all shares, or by either party with 5 days' notice, or registration statement expiry.

## SEC filing metadata
- accession: 0001185185-23-001111
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/0001185185-23-001111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/igcpharma20231027_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-001111
- JSON: https://secwatch.observer/filing/0001185185-23-001111.json
- Plain text: https://secwatch.observer/filing/0001185185-23-001111.txt

## Key facts
- Material Agreements
  IGC Pharma, Inc. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at up to $60 million.
  - Action: entry
  - Agreement: atm program
  - Counterparty: A.G.P./Alliance Global Partners
  - Value: up to $60 million
  source text: IGC Pharma, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with A.G.P./Alliance Global Partners (the “Agent”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518523001111/0001185185-23-001111-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.